{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T18:23:22Z","timestamp":1794248602100,"version":"4.9.0"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","license":[{"start":{"date-parts":[[2025,3,21]],"date-time":"2025-03-21T00:00:00Z","timestamp":1742515200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,3,21]]},"abstract":"<jats:sec>\n                    <jats:title>Rationale:<\/jats:title>\n                    <jats:p>Retroperitoneal liposarcoma (RPLS) is a rare malignancy with a high recurrence rate. Giant RPLS (\u226530\u2009cm) poses significant surgical challenges due to its invasive nature and compression of vital organs. Early diagnosis and multidisciplinary management are critical yet underreported in young patients. This case highlights the complexity of managing a 36-year-old male with a 60 cm\u2005\u00d7\u200550 cm\u2005\u00d7\u200540\u2009cm tumor, emphasizing the importance of surgical precision and collaborative care.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patient concerns:<\/jats:title>\n                    <jats:p>The patient is a 36-year-old male who was admitted to the hospital due to abdominal distension presenting for over 7 months, accompanied by a rapid increase in abdominal girth for over the past 2 months. Based on his symptoms, physical examination findings, and imaging studies, the possibility of a giant retroperitoneal liposarcoma was considered.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Diagnoses:<\/jats:title>\n                    <jats:p>Giant retroperitoneal liposarcoma.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions:<\/jats:title>\n                    <jats:p>The treatment involved the resection of the massive retroperitoneal tumor, along with partial resection of the descending colon, left ureterostomy drainage, and release of intestinal adhesions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Outcomes:<\/jats:title>\n                    <jats:p>The patient was discharged 14 days postoperatively with no immediate complications. Albumin levels improved to 35.2\u2009g\/L at 1-month follow-up. Telephone follow-ups at 3, 6, 12 months, and 5 years revealed no signs of recurrence on abdominal ultrasound.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Lessons:<\/jats:title>\n                    <jats:p>The tumor had already invaded the surrounding organ tissues at the time of discovery in this case. Comprehensive preoperative evaluation, multidisciplinary collaboration in diagnosis and treatment, precise surgical techniques, and standardized intraoperative and postoperative management are essential to enhance surgical resection rates, minimize complications, and decrease the likelihood of postoperative recurrence.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000041923","type":"journal-article","created":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T01:12:21Z","timestamp":1743037941000},"page":"e41923","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["A case report of giant retroperitoneal liposarcoma"],"prefix":"10.1097","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-3636-7952","authenticated-orcid":false,"given":"Zicheng","family":"Bao","sequence":"first","affiliation":[{"name":"Third Department of Surgery, Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-8389-8582","authenticated-orcid":false,"given":"Nan","family":"Jia","sequence":"additional","affiliation":[{"name":"Third Department of Surgery, Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhidong","family":"Zhang","sequence":"additional","affiliation":[{"name":"Third Department of Surgery, Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pingan","family":"Ding","sequence":"additional","affiliation":[{"name":"Third Department of Surgery, Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qun","family":"Zhao","sequence":"additional","affiliation":[{"name":"Third Department of Surgery, Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuefeng","family":"Zhao","sequence":"additional","affiliation":[{"name":"Third Department of Surgery, Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Li","sequence":"additional","affiliation":[{"name":"Third Department of Surgery, Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20261109","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1177\/1758834017705588","article-title":"Neoadjuvant chemotherapy in soft tissue sarcomas: latest evidence and clinical implications.","volume":"9","author":"Pasquali","year":"2017","journal-title":"Ther Adv Med Oncol"},{"key":"R2-20261109","first-page":"161","article-title":"Giant retroperitoneal liposarcoma. Report of 5 cases.","volume":"83","author":"Makni","year":"2012","journal-title":"Ann Ital Chir"},{"key":"R3-20261109","doi-asserted-by":"crossref","first-page":"3606","DOI":"10.3390\/diagnostics13243606","article-title":"The predictive role of the histopathological scoring system in adipose tumors-lipoma, atypical lipomatous tumor, and liposarcoma.","volume":"13","author":"Deacu","year":"2023","journal-title":"Diagnostics (Basel)"},{"key":"R4-20261109","doi-asserted-by":"crossref","first-page":"70","DOI":"10.32074\/1591-951X-213","article-title":"The 2020 WHO classification of soft tissue tumours: news and perspectives.","volume":"113","author":"Sbaraglia","year":"2021","journal-title":"Pathologica"},{"key":"R5-20261109","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.2169\/internalmedicine.46.0242","article-title":"Pelvic retroperitoneal liposarcoma diagnosed by preoperative imaging studies.","volume":"46","author":"Shibuya","year":"2007","journal-title":"Intern Med"},{"key":"R6-20261109","first-page":"129","article-title":"Surgical treatment of retroperitoneal liposarcoma.","volume":"57","author":"Ikeguchi","year":"2014","journal-title":"Yonago Acta Med"},{"key":"R7-20261109","doi-asserted-by":"crossref","first-page":"314","DOI":"10.3892\/ol.2022.13434","article-title":"Challenging surgical treatment of giant retroperitoneal liposarcoma: a case report.","volume":"24","author":"Wei","year":"2022","journal-title":"Oncol Lett"},{"key":"R8-20261109","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1245\/s10434-014-4210-8","article-title":"Accuracy of preoperative percutaneous biopsy for the diagnosis of retroperitoneal liposarcoma subtypes.","volume":"22","author":"Ikoma","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"R9-20261109","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/bjs.1800760423","article-title":"Surgical strategy in primary retroperitoneal tumours.","volume":"76","author":"Serio","year":"1989","journal-title":"Br J Surg"},{"key":"R10-20261109","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1200\/JCO.2000.18.8.1637","article-title":"Influence of biologic factors and anatomic site in completely resected liposarcoma.","volume":"18","author":"Linehan","year":"2000","journal-title":"J Clin Oncol"},{"key":"R11-20261109","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/00000658-199809000-00008","article-title":"Retroperitoneal soft-tissue sarcoma: analysis of 500 patients treated and followed at a single institution.","volume":"228","author":"Lewis","year":"1998","journal-title":"Ann Surg"},{"key":"R12-20261109","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1245\/s10434-010-1057-5","article-title":"Aggressive surgery in retroperitoneal soft tissue sarcoma carried out at high-volume centers is safe and is associated with improved local control.","volume":"17","author":"Bonvalot","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"R13-20261109","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1002\/bjs.6994","article-title":"Surgical management of primary retroperitoneal sarcoma.","volume":"97","author":"Strauss","year":"2010","journal-title":"Br J Surg"},{"key":"R14-20261109","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.ijrobp.2017.01.230","article-title":"Retroperitoneal liposarcoma: an aggressive strategy to maximize disease control.","volume":"98","author":"Pasquali","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R15-20261109","doi-asserted-by":"crossref","first-page":"e39633","DOI":"10.1097\/MD.0000000000039633","article-title":"A case report of retroperitoneal liposarcoma.","volume":"103","author":"Bao","year":"2024","journal-title":"Medicine (Baltimore)"},{"key":"R16-20261109","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1097\/SLA.0000000000001149","article-title":"Histology-based classification predicts pattern of recurrence and improves risk stratification in primary retroperitoneal sarcoma.","volume":"263","author":"Tan","year":"2016","journal-title":"Ann Surg"},{"key":"R17-20261109","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1007\/s11547-013-0350-3","article-title":"Radiation therapy for retroperitoneal sarcoma.","volume":"119","author":"Tuan","year":"2014","journal-title":"Radiol Med"},{"key":"R18-20261109","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1002\/bjs.10305","article-title":"Preoperative radiotherapy in the management of retroperitoneal liposarcoma.","volume":"103","author":"Ecker","year":"2016","journal-title":"Br J Surg"},{"key":"R19-20261109","doi-asserted-by":"crossref","first-page":"3459","DOI":"10.1038\/s41467-022-31014-y","article-title":"A sound approach to advancing healthcare systems: the future of biomedical acoustics.","volume":"13","author":"Rufo","year":"2022","journal-title":"Nat Commun"},{"key":"R20-20261109","doi-asserted-by":"crossref","first-page":"100123","DOI":"10.1016\/j.modpat.2023.100123","article-title":"Molecular landscape of mullerian clear cell carcinomas identifies the cancer genome atlas-like prognostic subgroups.","volume":"36","author":"Irshaid","year":"2023","journal-title":"Mod Pathol"},{"key":"R21-20261109","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1200\/JCO.22.02345","article-title":"CAR T-cells for cure in pediatric B-ALL.","volume":"41","author":"Gardner","year":"2023","journal-title":"J Clin Oncol"},{"key":"R22-20261109","doi-asserted-by":"crossref","first-page":"5696","DOI":"10.1158\/1078-0432.CCR-08-3185","article-title":"Clinical and biological significance of CDK4 amplification in well-differentiated and dedifferentiated liposarcomas.","volume":"15","author":"Italiano","year":"2009","journal-title":"Clin Cancer Res"},{"key":"R23-20261109","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2217\/fon.13.163","article-title":"Efficacy and safety of trabectedin as an early treatment for advanced or metastatic liposarcoma and leiomyosarcoma.","volume":"10","author":"Blay","year":"2014","journal-title":"Future Oncol"},{"key":"R24-20261109","doi-asserted-by":"crossref","first-page":"5979","DOI":"10.1021\/jm400487c","article-title":"Discovery of RG7388, a potent and selective p53-MDM2 inhibitor in clinical development.","volume":"56","author":"Ding","year":"2013","journal-title":"J Med Chem"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000041923","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T18:01:00Z","timestamp":1794247260000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000041923"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,21]]},"references-count":24,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000041923","relation":{},"ISSN":["1536-5964","0025-7974"],"issn-type":[{"value":"1536-5964","type":"electronic"},{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3,21]]}}}